Roivant Sciences Ltd.(NasdaqGS:ROIV) added to S&P 400
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.24 USD | -1.45% | +1.12% | +0.22% |
Apr. 05 | Arbutus Biopharma Obtains Favorable Court Order in Moderna Patent Lawsuit | MT |
Apr. 04 | Moderna Suffers Setback in Lawsuit by Arbutus | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.22% | 9.19B | |
+32.33% | 694B | |
+29.39% | 593B | |
-1.48% | 371B | |
+20.13% | 331B | |
+7.22% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.61% | 169B |
- Stock Market
- Equities
- ROIV Stock
- News Roivant Sciences Ltd.
- Roivant Sciences Ltd.(NasdaqGS: ROIV) added to S&P 400